The need to move away from fecal transplant towards targeted, refined microbiome therapy

Lindsey Russell¹, Tanya Monaghan^{2

3}, Dina Kao⁴

Affiliations

¹ Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
² NIHR Nottingham Digestive Diseases Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
³ Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingham, UK.
⁴ Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

Comment

Lindsey Russell et al. J Thorac Dis. 2018 Oct.

. 2018 Oct;10(10):E755-E757.

doi: 10.21037/jtd.2018.09.80.

Lindsey Russell¹, Tanya Monaghan^{2

3}, Dina Kao⁴

¹ Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
² NIHR Nottingham Digestive Diseases Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, UK.
³ Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingham, UK.
⁴ Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Microbiota replacement for Clostridium difficile by capsule is as effective as via colonoscopy.
Saha S, Khanna S. Saha S, et al. J Thorac Dis. 2018 Apr;10(Suppl 9):S1081-S1083. doi: 10.21037/jtd.2018.04.18. J Thorac Dis. 2018. PMID: 29849203 Free PMC article. No abstract available.

1. Saha S, Khanna S. Microbiota replacement for Clostridium difficile by capsule is as effective as via colonoscopy. J Thorac Dis 2018;10:S1081-3. 10.21037/jtd.2018.04.18 - DOI - PMC - PubMed
1. Baktash A, Terveer EM, Zwittink RD, et al. Mechanistic Insights in the Success of Fecal Microbiota Transplants for the Treatment of Clostridium difficile Infections. Front Microbiol 2018;9:1242. 10.3389/fmicb.2018.01242 - DOI - PMC - PubMed
1. Fernandez L, Rodriguez A, Garcia P. Phage or foe: an insight into the impact of viral predation on microbial communities. ISME J 2018;12:1171-9. 10.1038/s41396-018-0049-5 - DOI - PMC - PubMed
1. Meader E, Mayer MJ, Steverding D, et al. Evaluation of bacteriophage therapy to control Clostridium difficile and toxin production in an in vitro human colon model system. Anaerobe 2013;22:25-30. 10.1016/j.anaerobe.2013.05.001 - DOI - PubMed
1. Nale JY, Redgwell TA, Millard A, et al. Efficacy of an Optimised Bacteriophage Cocktail to Clear Clostridium difficile in a Batch Fermentation Model. Antibiotics (Basel) 2018;7. doi: .10.3390/antibiotics7010013 - DOI - PMC - PubMed